New Risk • Feb 09
New major risk - Revenue and earnings growth Earnings have declined by 3.6% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr50m free cash flow). Share price has been highly volatile over the past 3 months (54% average weekly change). Earnings have declined by 3.6% per year over the past 5 years. Shareholders have been substantially diluted in the past year (100% increase in shares outstanding). Revenue is less than US$1m (kr7.9m revenue, or US$880k). Market cap is less than US$10m (kr11.5m market cap, or US$1.28m). New Risk • Dec 03
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 100% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr47m free cash flow). Share price has been highly volatile over the past 3 months (34% average weekly change). Shareholders have been substantially diluted in the past year (100% increase in shares outstanding). Revenue is less than US$1m (kr1.8m revenue, or US$188k). Market cap is less than US$10m (kr12.1m market cap, or US$1.29m). Minor Risk Currently unprofitable and not forecast to become profitable over next 2 years (kr28m net loss in 2 years). Reported Earnings • Nov 30
Third quarter 2025 earnings released: kr2.38 loss per share (vs kr8.30 loss in 3Q 2024) Third quarter 2025 results: kr2.38 loss per share (improved from kr8.30 loss in 3Q 2024). Net loss: kr8.61m (loss narrowed 55% from 3Q 2024). New Risk • Aug 26
New major risk - Revenue size The company makes less than US$1m in revenue. This is considered a major risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr56m free cash flow). Share price has been highly volatile over the past 3 months (42% average weekly change). Revenue is less than US$1m. Market cap is less than US$10m (kr12.5m market cap, or US$1.30m). Minor Risk Currently unprofitable and not forecast to become profitable over next 2 years (kr34m net loss in 2 years). Board Change • Aug 18
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director Jenny Karlsson was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. お知らせ • May 20
Omnione S.A. cancelled the acquisition of Sileon AB (publ) (OM:SILEON) from Rieber & Søn As and others in a reverse merger transaction. Omnione S.A. proposed to acquire Sileon AB (publ) (OM:SILEON) from Rieber & Søn As and others in a reverse merger transaction on March 28, 2025. Omnione S.A. signed a letter of intent to acquire Sileon AB (publ) from Rieber & Søn As and others in a reverse merger transaction on March 31, 2025. The letter of intent suggests that Sileon acquires Omnio and issues new shares to Omnio's shareholders, entailing that Omnio's shareholders will own approximately 95 percent of the new outstanding shares after such a transaction. In connection to the RTO, sileon intends to issue warrants, free of charge, to its existing shareholders. The indicative terms states that the warrants will have a duration of 4 years and a strike price of SEK 20 per new share. In order to fund Sileon's operations until the RTO has been completed, Sileon and the Company’s largest shareholder, Rieber & Søn AS, intend to enter into a convertible loan agreement of approximately SEK 10 million (the “Convertible Loan”). The Convertible Loan is intended to mature on November 15, 2025 and have a conversion price of SEK 15 per share. DDM to undertake due diligence for the RTO. If a merger agreement is not entered into by May 5, 2025, the LOI will terminate. Fulfillment of the transaction, and final terms for the Transactions, is contingent on binding merger agreement is entered into and will be subject to a number of conditions, including approval of an extraordinary general meeting in Sileon and approval from Nasdaq Stockholm. Assuming that a merger agreement is entered into, The transaction is expected to close during the second quarter of 2025.
As of May 5, 2025. Sileon AB announced an extension of the Letter of Intent for a reverse takeover transaction with Omnione SA. The LOI's term and exclusivity have been extended until June 16, 2025, while all other terms and conditions of the transaction remain unchanged as per Letter of Intent dated March 31, 2025.
Omnione S.A. cancelled the acquisition of Sileon AB (publ) (OM:SILEON) from Rieber & Søn As and others in a reverse merger transaction on May 18, 2025. 
